Contemporary trends in in vivo and in vitro testing of chemical carcinogens: Minireview

Neoplasma

Volumn 48, Issue 6, 2001, Pages 425-434

  Slamenova D ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Classic rodent bioassay; Genotoxicity tests; Identification of carcinogens; Initiation promotion model; Neonatal animals; Transgenic animals

Indexed keywords

CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOASSAY; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOPLASM; NONHUMAN; RAT; SHORT SURVEY;

EID: 0035713122     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (66)

1. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans
2. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity among 222 chemicals tested in rodents by the USNCI/NTP
3. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals
4. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the USNCI/NTP
5. Use of short-term tests in determining the genotoxicity or nongenotoxicity of chemicals
6. Mutagenicity test schemes and guidelines: US EPA Office of Pollution Prevention and Toxics and Office of Pesticide Programs
7. The single cell gel electrophoresis: A potential tool for DNA analysis of the patients with hematological malignicies
8. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response
9. Screening assays for carcinogenic agents and mixtures: An appraisal based on data in the IARC Monograph series
10. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence for multiple pathways for tumour progression
11. Kinetics of wound-induced v-Ha-ras transgene expression and papilloma development in transgenic TG.AC mice
12. Global test for analysis of multiple tumour data from animal carcinogenicity experiments
13. Cytotoxicity versus transforming activity in chemically exposed Syrian hamster embryo cells
14. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA
15. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
16. IPSTP guidelines for the design and interpretation of the chronic rodent carcinogenicity bioassay
17. Long- and medium-term carcinogenicity studies in animals and short-term genotoxicity tests
18. Neonatal mouse assay for tumorigenicity: Alternative to the chronic rodent bioassay
19. The initiating and promoting elements in tumor production: An analysis of the effect of tar, benzpyrene and methylcholanthrene on rabbit skin
20. Evaluation of the newborn mouse model for chemical tumorigenesis
21. Notes to application of V79 netabolic cooperation assay for detection of potential tumor promoters
22. Use of transgenic animals in carcinogenesis studies
23. Efficient rescue of integrated shuttle vectors from transgenic mice: A model for studying mutations in vivo
24. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic TG.AC mice
25. Carcinogenesis studies: Results from 398 experiments on 104 chemicals from the U.S. National Toxicology Program
26. International conference on harmonisation of technical requirements for the registration of pharmaceuticals for human use. Harmonised guideline
27. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione s-transferase placental form positive foci in rats - An approach for a new medium-term bioassay system
28. Medium-term bioassays for carcinogens
29. Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice
30. Genetic toxicology testing requirements: Official and unofficial view from Europe
31. Development of a short-term, in vivo mutagenesis assay: The effects of methylation on the recovery of a lambda phage shuttle vector from transgenic mice
32. Carcinogen-specific mutational pattern in the p53 gene in UVB-radiation induced squamous cell carcinomas of the mouse skin
33. p53, the cellular gatekeeper for growth and division
34. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
35. Activation of the Ki-ras gene in spontaneous and chemically-induced lung tumors in CD-1 mice
36. Activation of the Ha-, Ki-, and N-ras genes in chemically-induced liver tumors from CD-1 mice
37. Chemicals classified by IARC: Their potency in tests for carcinogenicity in rodents and their genotoxicity and acute toxicity
38. Chemicals classified by IARC: An investigation of some of their toxicological characteristics
39. Susceptibility of transgenic mice carrying human prototype C-Ha-ras gene in a short-term carcinogenicity study of a vinyl carbamate and ras gene analysis of the induced tumors
40. High incidence of ultraviolet-B- or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene
41. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mice skin
42. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments
43. Design of two-year carcinogenicity experiments: Dose allocation, animal allocation and sacrifice times
44. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes
45. Mechanisms of DNA excision repair
46. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion
47. Alternative tests: Carcinogens as an example
48. Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests
49. Pre-screening of carcinogens by studying of DNA synthesis inhibition and gene mutations in mammalian cells
50. Responses of transgenic mouse lines p53+/- and TG.AC to agents tested in conventional carcinogenicity bioassays
51. Germ-line transmission of a mutated p53 gene in a cancer prone family with Li-Fraumeni syndrome
52. Current status and use of short/medium term models for carcinogenicity testing of pharmaceuticals - Scientific perspective
53. Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity
54. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a sink-finger domain
55. Transgenic mice models in chemical carcinogenesis studies
56. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models
57. Review of alternative methods of carcinogenicity testing and evaluation of human pharmaceuticals
58. Cloning and characterization of the mouse XPAC gene
59. Transgenic assays for mutations and cancer; current status and future perspectives
60. The clonal nature of gamma-glutamyl transpeptidase positive hepatic lesions induced by initiation promotion in ornithine carbamoyl-transferase mosaic mice
61. Rapid induction of more malignant tumours by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice
62. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: Premises, promises and performance